CALYPTE BIOMEDICAL CORP
DelistedCIK 899426fmd_1ZN8B1DNCHEJ7XXWK6VM1GPBC0Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2012, 11 periods
Latest annual · FY2012
Millions- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- (0)
Latest quarter · Q4 FY2012
Millions- Operating income
- (0)
- Net income
- (0)
CALYPTE BIOMEDICAL CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Operating income | -$955,000 | -$973,000 | 10-K 2014-06-24 · proof | |
| Net income | -$1.1 million | -$693,000 | 10-K 2014-06-24 · proof | |
| Cash from operating activities | -$682,000 | -$443,000 | 10-K 2014-06-24 · proof | |
| Total assets | $1.8 million | $2 million | -10% | 10-K 2014-06-24 · proof |
| Total liabilities | $7 million | $7.1 million | -0.6% | 10-K 2014-06-24 · proof |
| Cash and cash equivalents | $15,000 | $10,000 | +50% | 10-K 2014-06-24 · proof |
- What was CALYPTE BIOMEDICAL CORP's operating income in fiscal 2012?
- CALYPTE BIOMEDICAL CORP reported operating income of -$955,000 for fiscal 2012 (the year ended Dec 31, 2012), against -$973,000 the year before. Source: the 10-K filed with the SEC on Jun 24, 2014. SEC
- What was CALYPTE BIOMEDICAL CORP's net income in fiscal 2012?
- CALYPTE BIOMEDICAL CORP reported net income of -$1.1 million for fiscal 2012 (the year ended Dec 31, 2012), against -$693,000 the year before. Source: the 10-K filed with the SEC on Jun 24, 2014. SEC
- What was CALYPTE BIOMEDICAL CORP's cash from operating activities in fiscal 2012?
- CALYPTE BIOMEDICAL CORP reported cash from operating activities of -$682,000 for fiscal 2012 (the year ended Dec 31, 2012), against -$443,000 the year before. Source: the 10-K filed with the SEC on Jun 24, 2014. SEC
- What are CALYPTE BIOMEDICAL CORP's total assets?
- As of Dec 31, 2012, CALYPTE BIOMEDICAL CORP reported total assets of $1.8 million, against $2 million a year earlier (-10%). Source: the 10-K filed with the SEC on Jun 24, 2014. SEC
- What are CALYPTE BIOMEDICAL CORP's total liabilities?
- As of Dec 31, 2012, CALYPTE BIOMEDICAL CORP reported total liabilities of $7 million, against $7.1 million a year earlier (-0.6%). Source: the 10-K filed with the SEC on Jun 24, 2014. SEC
- What are CALYPTE BIOMEDICAL CORP's cash and cash equivalents?
- As of Dec 31, 2012, CALYPTE BIOMEDICAL CORP reported cash and cash equivalents of $15,000, against $10,000 a year earlier (+50%). Source: the 10-K filed with the SEC on Jun 24, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:899426&period_type=annual&limit=5"Information only, not investment advice.